Bladder cancer diagnostic technology company Pacific Edge has received a green light from US regulators that will reimburse the cost of their tests to be covered by universal retiree or low-income insurance programmes Medicare and Medicaid.
The Local Coverage Determination, a coverage specific
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
